· b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240...

26

Transcript of  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240...

Page 1:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 2:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 3:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 4:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 5:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 6:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 7:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 8:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 9:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 10:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 11:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 12:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 13:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 14:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 15:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 16:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 17:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 18:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 19:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 20:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 21:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 22:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 23:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 24:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 25:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3
Page 26:  · b orc 0 [14C] 10 mg MIO) —b, 24.20/0&ËbÏco 0.65 24 50 30 12 72 96 120 144 168 192 216 240 264 288 312 Time (h) Total Radioactivity (14C) in Plasma o 100 10 0.1 48 0.01 o 27.2-3

14c. Computer Systems Extra Storage

14c. Computer Systems Extra Storage

Detailed Map_revised 4 17 14c

Detailed Map_revised 4 17 14c

14C Campaign Blogs

14C Campaign Blogs

14c-Olfactory & Gustatory Physiology

14c-Olfactory & Gustatory Physiology

2009 Info Stmt-schedule 14c

2009 Info Stmt-schedule 14c

Novatel U740 Firmware Upgrade 27.2 Release Notes.doc.doc

Novatel U740 Firmware Upgrade 27.2 Release Notes.doc.doc

14C Luciferin Kinetics

14C Luciferin Kinetics

27.2 Human Traits

27.2 Human Traits

Chapter 27 Pricing Math Section 27.1 Calculating Prices Section 27.2 Calculating Discounts Section 27.1 Calculating Prices Section 27.2 Calculating Discounts.

Chapter 27 Pricing Math Section 27.1 Calculating Prices Section 27.2 Calculating Discounts Section 27.1 Calculating Prices Section 27.2 Calculating Discounts.

PJM Manual 14C

PJM Manual 14C

SkeletalMuscleAMP-activatedProteinKinaseIsEssentialfor … · 2009-10-07 · 15min.Theupperaqueousphase(containing2-[14C]DG)wasusedtodetermine2-[14C]DG-Pasdescribedpreviously(29).Aportion

SkeletalMuscleAMP-activatedProteinKinaseIsEssentialfor … · 2009-10-07 · 15min.Theupperaqueousphase(containing2-[14C]DG)wasusedtodetermine2-[14C]DG-Pasdescribedpreviously(29).Aportion

Concept 27.2

Concept 27.2

27.1 INTRODUCTION 27.2 LEGAL AUTHORITY

27.1 INTRODUCTION 27.2 LEGAL AUTHORITY

PDF in Dutch 27.2 MB

PDF in Dutch 27.2 MB

14C Enabled Drug Development - EBF

14C Enabled Drug Development - EBF

Chapter 27.2

Chapter 27.2

A9R19cjvg6 gqb1k2 14c

A9R19cjvg6 gqb1k2 14c

Phylum Nematoda (Chapter 27.2)

Phylum Nematoda (Chapter 27.2)

Body's Defenses Ch 27.2 7th

Body's Defenses Ch 27.2 7th

27.2 red scare

27.2 red scare